本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nurix Therapeutics

24.50
-1.0200-4.00%
成交量:28.81萬
成交額:709.96萬
市值:25.33億
市盈率:-7.18
高:25.50
開:25.47
低:24.36
收:25.52
52周最高:28.23
52周最低:8.20
股本:1.03億
流通股本:9,504.52萬
量比:0.53
換手率:0.30%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
淨資產收益率:-80.30%
總資產收益率:-40.06%
市淨率:6.29
市盈率(LYR):-8.03

資料載入中...

2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/10

重要事件披露

Form 8-K - Current report
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors